Ewy Mathe

Title: Ewy Mathe: Innovator in Cancer Diagnosis and Prognosis

Introduction

Ewy Mathe is a notable inventor based in Bethesda, MD (US), recognized for his contributions to the field of cancer diagnosis and prognosis. With a total of 2 patents, Mathe has made significant strides in developing methods that enhance the detection and understanding of cancer.

Latest Patents

Mathe's latest patents focus on innovative methods for diagnosing cancer using various biological samples. The first patent outlines a method that utilizes tissue, blood, or urine samples to determine the levels of specific metabolites, including creatine riboside, metabolite 561+, cortisol sulfate, and N-acetylneuraminic acid. This method not only aids in diagnosing cancer but also provides a means for determining the prognosis of cancer patients. Additionally, the patent includes the development of kits designed for detecting cancer and assessing patient prognosis.

Career Highlights

Ewy Mathe is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing medical research and improving patient outcomes through innovative diagnostic methods.

Collaborations

Mathe collaborates with esteemed colleagues, including Majda Haznadar and Andrew D. Patterson. These partnerships enhance the research and development of effective cancer diagnostic tools.

Conclusion

Ewy Mathe's contributions to cancer diagnosis and prognosis exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements that can significantly improve patient care and outcomes.